PharmaEngine, Inc. (TPEX: 4162)
Taiwan
· Delayed Price · Currency is TWD
99.90
-1.60 (-1.58%)
Nov 15, 2024, 1:30 PM CST
PharmaEngine Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 14, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Market Capitalization | 13,822 | 15,158 | 17,961 | 10,207 | 8,430 | 9,978 | Upgrade
|
Market Cap Growth | 3.11% | -15.60% | 75.96% | 21.08% | -15.52% | -39.99% | Upgrade
|
Enterprise Value | 10,089 | 11,619 | 14,348 | 6,496 | 5,058 | 6,511 | Upgrade
|
Last Close Price | 96.20 | 103.65 | 119.78 | 67.42 | 51.50 | 60.50 | Upgrade
|
PE Ratio | 37.43 | 55.19 | 56.34 | 23.96 | 13.95 | 234.50 | Upgrade
|
Forward PE | 11.62 | 10.85 | 10.85 | 28.38 | 109.54 | 244.64 | Upgrade
|
PS Ratio | 16.61 | 19.75 | 27.45 | 15.59 | 7.98 | 31.77 | Upgrade
|
PB Ratio | 3.47 | 3.92 | 4.64 | 2.59 | 2.10 | 2.86 | Upgrade
|
P/TBV Ratio | 3.23 | 3.93 | 4.64 | 2.59 | 2.10 | 2.87 | Upgrade
|
P/FCF Ratio | 33.71 | 59.08 | 90.45 | 10.98 | 130.16 | 628.74 | Upgrade
|
P/OCF Ratio | 31.30 | 58.99 | 88.91 | 10.98 | 130.16 | 620.61 | Upgrade
|
EV/Sales Ratio | 12.13 | 15.14 | 21.93 | 9.92 | 4.79 | 20.73 | Upgrade
|
EV/EBITDA Ratio | 25.10 | 41.71 | 50.62 | 17.88 | 6.23 | 183.00 | Upgrade
|
EV/EBIT Ratio | 25.69 | 41.92 | 50.75 | 17.91 | 6.25 | 199.66 | Upgrade
|
EV/FCF Ratio | 24.61 | 45.29 | 72.26 | 6.99 | 78.09 | 410.26 | Upgrade
|
Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 | 0.01 | Upgrade
|
Debt / EBITDA Ratio | 0.02 | 0.05 | 0.08 | 0.02 | 0.03 | 0.84 | Upgrade
|
Debt / FCF Ratio | 0.02 | 0.06 | 0.11 | 0.01 | 0.34 | 2.07 | Upgrade
|
Asset Turnover | 0.21 | 0.19 | 0.16 | 0.16 | 0.27 | 0.08 | Upgrade
|
Inventory Turnover | 2.58 | 1.94 | 2.50 | 2.46 | 1.52 | 1.46 | Upgrade
|
Quick Ratio | 53.46 | 46.50 | 49.34 | 45.57 | 22.41 | 25.67 | Upgrade
|
Current Ratio | 53.67 | 46.78 | 49.86 | 45.71 | 22.61 | 25.85 | Upgrade
|
Return on Equity (ROE) | 9.48% | 7.10% | 8.16% | 10.72% | 16.13% | 1.19% | Upgrade
|
Return on Assets (ROA) | 6.17% | 4.37% | 4.42% | 5.51% | 12.89% | 0.54% | Upgrade
|
Return on Capital (ROIC) | 6.27% | 4.46% | 4.51% | 5.68% | 13.41% | 0.57% | Upgrade
|
Earnings Yield | 2.67% | 1.81% | 1.77% | 4.17% | 7.17% | 0.43% | Upgrade
|
FCF Yield | 2.97% | 1.69% | 1.11% | 9.11% | 0.77% | 0.16% | Upgrade
|
Dividend Yield | 1.55% | 1.45% | 1.67% | 4.00% | 4.85% | 0.83% | Upgrade
|
Payout Ratio | 58.21% | 104.57% | 121.62% | 85.44% | 12.05% | 342.34% | Upgrade
|
Buyback Yield / Dilution | -0.03% | -0.03% | 0.72% | 0.80% | -0.11% | 1.27% | Upgrade
|
Total Shareholder Return | 1.53% | 1.42% | 2.39% | 4.80% | 4.74% | 2.09% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.